AstraZeneca

News

AZ expands role in China, to include robots and health tech

AstraZeneca is planning to expand its role as a drug supplier in China to becoming a wider provider of healthcare through its use of robotics and other tech.

News

AZ's new leukaemia drug approved in the US

Lumoxis is first drug for hairy cell leukaemia in 20 years

News

Amgen/AZ's phase 3 asthma biologic could get fast review

Tezepelumab could be used in more patients than marketed IL-5 asthma drugs

News

Breakthrough designation AstraZeneca's severe asthma drug

The first-in class medicine for severe asthma co-developed by AstraZeneca and Amgen is poised for accelerated approval after the US Food and Drug Administration granted it a breakthrough de

News

AZ's lupus drug fails in late-stage trial

AZ will launch full review after further phase 3 results later this year

News

AstraZeneca improves diabetes pen to maintain its market sha...

The European Commission (EC) has approved AstraZeneca’s Bydureon BCise, a new weekly formulation of established GLP-1 diabetes drug with the added benefit of glucose reduct

AZ expands role in China, to include robots and health tech

AZ's new leukaemia drug approved in the US

Amgen/AZ's phase 3 asthma biologic could get fast review

Breakthrough designation AstraZeneca's severe asthma drug

AZ's lupus drug fails in late-stage trial

AstraZeneca improves diabetes pen to maintain its market sha...

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

AstraZeneca

Editor's Picks